Print

New ANDA Cases

Case Name

Date Filed

Judge

Drug

Patent No(s).

Forest Labs., Inc. v. First Time US Generics LLC, 13-1642 (D. Del.)

Oct. 2, 2013

Hon. Sue L. Robinson

Savella® (milnacipran hydrochloride tablets)

6,602,911

7,888,342

7,994,220

Ferring B.V. v. Mylan Inc., 13-5909 (E.D. Pa)

Oct. 7, 2013

Hon. Norma L. Shapiro

Lysteda® (tranexamic acid tablets)

7,947,739

8,022,106

8,273,795

8,487,005

Reckitt Benckiser Pharma., Inc. v. Watson Labs., Inc., 13-1674 (D. Del.)

Oct. 8, 2013

Hon. Richard G. Andrews

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832

8,017,150

Cubist Pharma., Inc. v. Strides, Inc., 13-1679 (D. Del.)

Oct. 9, 2013

Hon. Gregory M. Sleet

Cubicin® (daptomycin for injection)

6,468,967

6,852,689

8,058,238

8,129,342

Cubist Pharma., Inc. v. Strides, Inc., 13-6016 (D.N.J.)

Oct. 9, 2013

Hon. Noel L. Hillman

Cubicin® (daptomycin for injection)

6,468,967

6,852,689

8,058,238

8,129,342

Baxter Healthcare Corp. v. HQ Specialty Pharma Corp., 13-13-6228 (D.N.J.)

Oct. 18, 2013

Hon. Faith S. Hochberg

Brevibloc® (esmolol hydrochloride in sodium chloride for injection)

6,310,094

6,528,540

Takeda Pharma. USA, Inc. v. Amneal Pharma., LLC, 13-1729 (D. Del.)

Oct. 21, 2013

Hon. Sue L. Robinson

Colcrys® (colchicine, USP)

7,906,519

7,935,731

8,093,298

7,964,648

8,093,297

Forest Labs., Inc. v. Amneal Pharma., LLC, 13-1737 (D. Del.)

Oct. 21, 2013

Hon. Sue L. Robinson

Savella® (milnacipran hydrochloride tablets)

6,602,911

7,888,342

7,994,220

Cephalon, Inc. v. Eagle Pharma., Inc., 13-1738 (D. Del.)

Oct. 21, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

Horizon Pharma AG v. Par Pharma. Cos., Inc., 13-6298 (D.N.J.)

Oct. 22, 2013

Hon. Joseph E. Irenas

Rayos® (prednisone delayed-release tablets)

6,488,960

6,677,326

8,309,124

8,168,218

8,394,407

AstraZeneca AB v. Dr. Reddy’s Labs. Inc., 13-6157 (D.N.J.)

Oct. 23, 2013

Hon. Joel A. Pisano

Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)

8,557,285

AstraZeneca AB v. Lupin Ltd., 13-6315 (D.N.J.)

Oct. 23, 2013

Hon. Joel A. Pisano

Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)

8,557,285

AstraZeneca AB v. Mylan Pharma., 13-6316 (D.N.J.)

Oct. 23, 2013

Hon. Joel A. Pisano

Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)

8,557,285

AstraZeneca AB v. Watson Labs., Inc.-Florida, 13-6318 (D.N.J.)

Oct. 23, 2013

Hon. Joel A. Pisano

Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)

8,557,285

Warner Chilcott Co., LLC v. Impax Labs., Inc., 13-6403 (D.N.J.)

Oct. 23, 2013

Hon. Faith S. Hochberg

Atelvia® (risedronate sodium delayed-release tablets)

7,645,459

7,645,460

8,246,989

Dow Pharma. Sciences, Inc. v. Actavis, Inc., 13-6401 (D.N.J.)

Oct. 24, 2013

Hon. Stanley R. Chesler

Acanya® (clindamycin phosphate / benzoyl peroxide gel)

8,288,434

Takeda Pharma. Co. Ltd. v. Wockhardt Bio AG, 13-6427 (D.N.J.)

Oct. 25, 2013

Hon. Joel A. Pisano

Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)

6,328,994

7,431,942

7,399,485

7,875,292

Ferring B.V. v. Apotex Inc., 13-0595 (D. Nev.)

Oct. 25, 2013

Hon. Larry R. Hicks

Lysteda® (tranexamic acid tablets)

8,487,005

Reckitt Benckiser Pharma., Inc. v. BioDelivery Sciences Int’l Inc., 13-0760 (E.D.N.C.)

Oct. 29, 2013

Hon. Terrence W. Boyle

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832

Cipher Pharma., Inc. v. Watson Labs., Inc.--Florida, 13-6502 (D.N.J.)

Oct. 29, 2013

Hon. Kevin McNulty

Absorica® (isotretinoin capsules)

8,367,102

Warner Chilcott Co., LLC v. Mylan, Inc., 13-6560 (N.J.D.)

Oct. 30, 2013

Hon. Joel A. Pisano

Lo Loestrin® Fe (norethindrone acetate / ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets)

7,704,984

Teijin Ltd. v. Dr. Reddy’s Labs., Ltd., 13-1780 (D. Del.)

Oct. 30, 2013

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Teijin Ltd. v. Mylan Pharma. Inc., 13-1781 (D. Del.)

Oct. 30, 2013

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Otsuka Pharma. Co., Ltd. v. Wockhardt Ltd., 13-6604 (D.N.J.)

Oct. 31, 2013

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

6,977,257

Apotex Inc. v. Wyeth LLC, IPR2014-00115 (PTAB)

Nov. 1, 2013

N/A

Tygacil® (tigecycline injection)

7,879,828

Purdue Pharma L.P. v. Sandoz Inc., 13-7776 (S.D.N.Y.)

Nov. 1, 2013

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended-release tablets)

8,337,888

8,309,060

Forest Labs., Inc. v. Sandoz Inc., 13-1830 (D. Del.)

Nov. 4, 2013

Hon. Sue L. Robinson

Savella® (milnacipran hydrochloride tablets)

6,602,911

7,888,342

7,994,220

Teijin Ltd. v. Apotex Inc., 13-1851 (D. Del.)

Nov. 6, 2013

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Teijin Ltd. v. Sun Pharma Global FZE, 13-1852 (D. Del.)

Nov. 6, 2013

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Millenium Pharma., Inc. v. Apotex Corp., 13-1874 (D. Del.)

Nov. 8, 2013

Hon. Gregory M. Sleet

Velcade® (bortezomib injection)

6,713,446

6,958,319

Genzyme Corp. v. Dr. Reddy’s Labs., Inc., 13-6827 (D.N.J.)

Nov. 8, 2013

Hon. Joseph E. Irenas

Clolar® (clofarabine injection)

5,661,136

Novartis Pharma. Corp. v. Akorn, Inc., 13-6835 (D.N.J.)

Nov. 8, 2013

Hon. Susan D. Wigenton

Zometa® (zoledronic acid injection)

7,932,241

8,324,189

Eli Lilly and Co. v. Watson Labs., Inc., 13-1799 (S.D. Ind.)

Nov. 12, 2013

Hon. Jane Magnus-Stinson

Axiron® (testosterone topical solution)

6,299,900

6,818,226

6,923,983

8,071,075

8,419,307

8,435,944

Pfizer Inc. v. Fresenius Kabi USA, LLC, 13-1893 (D. Del.)

Nov. 13, 2013

Hon. Sue L. Robinson

Tygacil® (tigecycline injection)

RE40,183

7,879,828

8,372,995

Eli Lilly and Co. v. Watson Labs., Inc., 13-0637 (D. Nev.)

Nov. 14, 2013

Hon. William G. Cobb

Axiron® (testosterone topical solution)

6,299,900

6,818,226

6,923,983

8,071,075

8,419,307

8,435,944

Janssen Pharma., Inc. v. Sandoz Inc., 13-6929 (D.N.J.)

Nov. 14, 2013

Hon. Claire C. Cecchi

Nucynta® (tapentadol hydrochloride tablets)

RE39,593

7,994,364

Janssen Pharma., Inc. v. Roxane Labs., Inc., 13-0639 (D. Nev.)

Nov. 15, 2013

Hon. Miranda M. Du

Nucynta® (tapentadol hydrochloride tablets)

RE39,593

7,994,364

Millenium Pharma., Inc. v. Apotex Corp., 13-8240 (N.D. Ill.)

Nov. 15, 2013

Hon. Milton I. Shadur

Velcade® (bortezomib injection)

6,713,446

6,958,319

Dow Pharma. Sciences, Inc. v. Perrigo Co., 13-6922 (D.N.J.)

Nov. 15, 2013

Hon. Stanley R. Chesler

Acanya® (clindamycin phosphate / benzoyl peroxide gel)

8,288,434

Amneal Pharma., LLC v. Endo Pharma. Inc., IPR2014-00160 (PTAB)

Nov. 18, 2013

N/A

Opana® ER (oxymorphone hydrochloride extended-release tablets)

7,851,482

Teijin Ltd. v. Alembic Pharma. Ltd., 13-1939 (D. Del.)

Nov. 19, 2013

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Shire LLC v. Apotex, Inc., 13-1965 (D. Del.)

Nov. 21, 2013

Hon. Richard G. Andrews

Intuniv® (guanfacine hydrochloride extended-release tablets)

6,287,599

6,811,794

Shire LLC v. Apotex, Inc., 13-24236 (S.D. Fla.)

Nov. 21, 2013

Hon. Jose E. Martinez

Intuniv® (guanfacine hydrochloride extended-release tablets)

6,287,599

6,811,794

Novartis Pharma. Corp. v. Roxane Labs., Inc., 13-1973 (D. Del.)

Nov. 25, 2013

Hon. Gregory M. Sleet

Fanapt® (iloperidone tablets)

RE39,198

Otsuka Pharma. Co., Ltd. v. Par Pharma., Inc., 13-1979 (D. Del.)

Nov. 26, 2013

Hon. Richard G. Andrews

Samsca® (tolvaptan tablets)

5,753,677

8,501,730

Novartis Pharma. Corp. v. Accord Healthcare Inc., 13-7178 (D.N.J.)

Nov. 26, 2013

Hon. Susan D. Wigenton

Zometa® (zoledronic acid injection)

8,324,189

Novartis Pharma. Corp. v. Roxane Labs., Inc., 13-7184 (D.N.J.)

Nov. 27, 2013

Hon. Noel L. Hillman

Fanapt® (iloperidone tablets)

RE39,198

Janssen Products, L.P. v. Teva Pharma. USA, Inc., 13-7576 (D.N.J.)

Nov. 27, 2013

Hon. William H. Walls

Prezista® (darunavir tablets)

8,518,987

Idenix Pharma., Inc. v. Gilead Sciences, Inc., 13-1987 (D. Del.)

Dec. 1, 2013

Hon. Leonard P. Stark

Sovaldi® (sofosbuvir tablets)

7,608,600

Idenix Pharma., Inc. v. Gilead Sciences, Inc., 13-13052 (D. Mass.)

Dec. 1, 2013

Hon. Leo T. Sorokin

Sovaldi® (sofosbuvir tablets)

6,914,054

7,608,597

AstraZeneca AB v. Aurobindo Pharma Ltd., 13-7298 (D.N.J.)

Dec. 3, 2013

Hon. Joel A. Pisano

Nexium® (esomeprazole magnesium delayed-release tablets)

5,714,504

6,369,085

7,411,070

8,466,175

AstraZeneca AB v. Kremers Urban Pharma., 13-7299 (D.N.J.)

Dec. 3, 2013

Hon. Joel A. Pisano

Nexium® (esomeprazole magnesium delayed-release tablets)

5,714,504

6,369,085

7,411,070

8,466,175

Endo Pharma., Inc. v. Ranbaxy Labs., Ltd., 13-8597 (S.D.N.Y.)

Dec. 3, 2013

Hon. Thomas P. Griesa

Opana® ER (oxymorphone hydrochloride extended-release tablets)

7,851,482

8,309,122

8,329,216

Teva Pharma. USA, Inc. v. Forest Labs., Inc., 13-2002 (D. Del.)

Dec. 5, 2013

Hon. Gregory M. Sleet

Namenda XR® (memantine extended-release capsules)

6,194,000

Reckitt Benckiser Pharma., Inc. v. Alvogen Pine Brook, Inc., 13-2003 (D. Del.)

Dec. 6, 2013

Hon. Richard G. Andrews

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832

8,017,150

Pfizer Inc. v. Hetero USA Inc., 13-2021 (D. Del.)

Dec. 11, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Pfizer Inc. v. Apotex Inc., 13-2022 (D. Del.)

Dec. 11, 2013

Hon. Gregory M. Sleet

Toviaz® (fesoterodine fumarate extended-release tablets)

6,858,650

7,384,980

7,855,230

7,985,772

8,338,478

Warner Chilcott Co., LLC v. Torrent Pharma. Ltd., 13-2039 (D. Del.)

Dec. 18, 2013

Hon. Gregory M. Sleet

Enablex® (darifenacin hydrobromide extended-release tablets)

6,106,864

Alcon Research, Ltd. v. Wockhardt Ltd., 13-2040 (D. Del.)

Dec. 19, 2013

Hon. Sue L. Robinson

Travatan Z® (travoprost ophthalmic solution)

8,268,299

8,323,630

8,388,941

IGI Labs., Inc. v. Mallinckrodt, LLC, 13-2044 (D. Del.)

Dec. 19, 2013

Hon. Richard G. Andrews

Pennsaid® (diclofenac sodium topical solution 1.5%)

8,217,078

8,546,450

Cephalon, Inc. v. Hetero Labs. Ltd., 13-2046 (D. Del.)

Dec. 19, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

Cephalon, Inc. v. Agila Specialties, Inc., 13-2080 (D. Del.)

Dec. 20, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

8,436,190

Cephalon, Inc. v. Innopharma, Inc., 13-2081 (D. Del.)

Dec. 20, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

8,436,190

Cephalon, Inc. v. Dr. Reddy’s Labs., Ltd., 13-2082 (D. Del.)

Dec. 20, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

8,436,190

Janssen Pharma., Inc. v. Aklem Labs., Ltd., 13-7803 (D.N.J.)

Dec. 23, 2013

Hon. Claire C. Cecchi

Nucynta® ER (tapentadol hydrochloride extended-release tablets)

8,536,130

Teijin Ltd. v. Zydus Pharma. USA, Inc., 13-2086 (D. Del.)

Dec. 23, 2013

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

7,361,676

Merck Sharp & Dohme B.V. v. Warner Chilcott Co., LLC, 13-2088 (D. Del.)

Dec. 24, 2013

Hon. Gregory M. Sleet

NuvaRing® (ethinyl estradiol / etonogestrel vaginal ring)

5,989,581

Cephalon, Inc. v, 13-Glenmark Pharma., Ltd., 13-2093 (D. Del.)

Dec. 26, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

Cephalon, Inc. v, 13-Hospira, Inc., 13-2094 (D. Del.)

Dec. 26, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,436,190

8,445,524

Cephalon, Inc. v, 13-Accord Healthcare, Inc., 13-2095 (D. Del.)

Dec. 26, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,436,190

8,445,524

Cephalon, Inc. v, 13-Sun Pharma Global FZE, 13-2096 (D. Del.)

Dec. 26, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,436,190

8,445,524

Janssen Pharma., Inc. v. Aklem Labs., Ltd., 13-9227 (N.D. Ill.)

Dec. 26, 2013

Hon. James F. Holderman

Nucynta® ER (tapentadol hydrochloride extended-release tablets)

8,536,130

Helsinn Healthcare S.A. v. Accord Healthcare, Inc., 13-2101 (D. Del.)

Dec. 27, 2013

Hon. Gregory M. Sleet

Aloxi® (palonosetron hydrochloride injection)

8,598,218

8,598,219

Jazz Pharma., Inc. v. Par Pharma., Inc., 13-7884 (D.N.J.)

Dec. 27, 2013

Hon. Esther Salas

Xyrem® (sodium oxybate oral solution)

6,472,431

6,780,889

7,262,219

7,851,506

8,263,650

8,324,275

8,461,203

7,668,730

7,765,106

7,765,107

7,895,059

8,457,988

8,589,182

Novartis Pharma. Corp. v. Fresenius Kabi USA, LLC, 13-7914 (D.N.J.)

Dec. 27, 2013

Hon. Susan D. Wigenton

Zometa® (zoledronic acid injection)

8,324,189

Cephalon, Inc. v. Sandoz Inc., 13-2104 (D. Del.)

Dec. 31, 2013

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,436,190

8,445,524

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.